NABORS INDUSTRIES LTD (NBR)

BMG6359F1370 - Common Stock

53.77  -1.02 (-1.86%)

After market: 53.77 0 (0%)

Fundamental Rating

3

NBR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 59 industry peers in the Energy Equipment & Services industry. NBR has a bad profitability rating. Also its financial health evaluation is rather negative. NBR does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

NBR had negative earnings in the past year.
In the past year NBR had a positive cash flow from operations.
NBR had negative earnings in each of the past 5 years.
Each year in the past 5 years NBR had a positive operating cash flow.

1.2 Ratios

NBR has a worse Return On Assets (-3.71%) than 76.27% of its industry peers.
NBR's Return On Equity of -88.32% is on the low side compared to the rest of the industry. NBR is outperformed by 94.92% of its industry peers.
NBR has a worse Return On Invested Capital (4.99%) than 64.41% of its industry peers.
Industry RankSector Rank
ROA -3.71%
ROE -88.32%
ROIC 4.99%
ROA(3y)-6.37%
ROA(5y)-9.06%
ROE(3y)-70.55%
ROE(5y)-64.36%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 8.59%, NBR perfoms like the industry average, outperforming 47.46% of the companies in the same industry.
NBR's Gross Margin of 40.75% is amongst the best of the industry. NBR outperforms 83.05% of its industry peers.
In the last couple of years the Gross Margin of NBR has grown nicely.
Industry RankSector Rank
OM 8.59%
PM (TTM) N/A
GM 40.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y2.73%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NBR is destroying value.
Compared to 1 year ago, NBR has more shares outstanding
NBR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NBR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.41, we must say that NBR is in the distress zone and has some risk of bankruptcy.
NBR has a worse Altman-Z score (0.41) than 81.36% of its industry peers.
The Debt to FCF ratio of NBR is 20.78, which is on the high side as it means it would take NBR, 20.78 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.78, NBR is not doing good in the industry: 62.71% of the companies in the same industry are doing better.
NBR has a Debt/Equity ratio of 13.08. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 13.08, NBR is not doing good in the industry: 93.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 13.08
Debt/FCF 20.78
Altman-Z 0.41
ROIC/WACC0.71
WACC7.05%

2.3 Liquidity

A Current Ratio of 1.88 indicates that NBR should not have too much problems paying its short term obligations.
NBR has a Current ratio (1.88) which is in line with its industry peers.
A Quick Ratio of 1.63 indicates that NBR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.63, NBR is doing good in the industry, outperforming 66.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.63

3

3. Growth

3.1 Past

NBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.79%.
NBR shows a decrease in Revenue. In the last year, the revenue decreased by -3.76%.
Measured over the past years, NBR shows a decrease in Revenue. The Revenue has been decreasing by -0.34% on average per year.
EPS 1Y (TTM)-51.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.71%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y12.1%
Revenue growth 5Y-0.34%
Sales Q2Q%-0.11%

3.2 Future

The Earnings Per Share is expected to grow by 34.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.77% on average over the next years.
EPS Next Y-224.14%
EPS Next 2Y32.11%
EPS Next 3Y34.76%
EPS Next 5YN/A
Revenue Next Year-2.78%
Revenue Next 2Y4.44%
Revenue Next 3Y4.77%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

NBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

NBR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NBR is cheaper than 93.22% of the companies in the same industry.
NBR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NBR is cheaper than 91.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.78
EV/EBITDA 2.94

4.3 Compensation for Growth

NBR's earnings are expected to grow with 34.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.11%
EPS Next 3Y34.76%

0

5. Dividend

5.1 Amount

No dividends for NBR!.
Industry RankSector Rank
Dividend Yield N/A

NABORS INDUSTRIES LTD

NYSE:NBR (12/20/2024, 8:26:34 PM)

After market: 53.77 0 (0%)

53.77

-1.02 (-1.86%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners73.2%
Inst Owner Change-3.24%
Ins Owners7.4%
Ins Owner Change0%
Market Cap575.88M
Analysts52.22
Price Target90.78 (68.83%)
Short Float %13.79%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-72.49%
DP-0.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-107.9%
Min EPS beat(2)-129.44%
Max EPS beat(2)-86.37%
EPS beat(4)0
Avg EPS beat(4)-126.32%
Min EPS beat(4)-169.97%
Max EPS beat(4)-86.37%
EPS beat(8)1
Avg EPS beat(8)-991.43%
EPS beat(12)2
Avg EPS beat(12)-667.96%
EPS beat(16)3
Avg EPS beat(16)-502.76%
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.59%
Revenue beat(4)1
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)1.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.18%
Revenue beat(12)5
Avg Revenue beat(12)-0.68%
Revenue beat(16)9
Avg Revenue beat(16)0.31%
PT rev (1m)-1.39%
PT rev (3m)-15.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1123.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-52.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.67%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 4.78
P/OCF 0.94
P/B 3.01
P/tB 3.01
EV/EBITDA 2.94
EPS(TTM)-15.68
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)11.25
FCFY20.92%
OCF(TTM)57.37
OCFY106.7%
SpS273.21
BVpS17.87
TBVpS17.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.71%
ROE -88.32%
ROCE 6.31%
ROIC 4.99%
ROICexc 5.65%
ROICexgc 5.65%
OM 8.59%
PM (TTM) N/A
GM 40.75%
FCFM 4.12%
ROA(3y)-6.37%
ROA(5y)-9.06%
ROE(3y)-70.55%
ROE(5y)-64.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y2.73%
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 13.08
Debt/FCF 20.78
Debt/EBITDA 2.81
Cap/Depr 77.4%
Cap/Sales 16.88%
Interest Coverage 250
Cash Conversion 69.07%
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.63
Altman-Z 0.41
F-Score4
WACC7.05%
ROIC/WACC0.71
Cap/Depr(3y)58.07%
Cap/Depr(5y)49.19%
Cap/Sales(3y)14.61%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.71%
EPS Next Y-224.14%
EPS Next 2Y32.11%
EPS Next 3Y34.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y12.1%
Revenue growth 5Y-0.34%
Sales Q2Q%-0.11%
Revenue Next Year-2.78%
Revenue Next 2Y4.44%
Revenue Next 3Y4.77%
Revenue Next 5YN/A
EBIT growth 1Y1.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year247.72%
EBIT Next 3Y64.24%
EBIT Next 5YN/A
FCF growth 1Y56.02%
FCF growth 3Y-14.33%
FCF growth 5YN/A
OCF growth 1Y52.32%
OCF growth 3Y22.17%
OCF growth 5Y14.38%